Rohto Pharma Of Japan Open To Acquisition, Expansion In China
This article was originally published in PharmAsia News
Executive Summary
Japan's Rohto Pharma has decided to remain independent, although President Toshiaki Yoshino, just three months into the job, says he is not opposed to new acquisitions that would help Rohto expand. But he also wants to avoid the company being a takeover target and is looking to apply its pharmaceutical technology to help it deal with setbacks experienced under recent changes in the Pharmaceutical Affairs Law governing over-the-counter and mail-order drugs. He said Rohto also is expanding its operations in China. (Click here for more - a subscription may be required